Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Investor Relations
Contact
Community

PRESS RELEASES

Webcast

TRACON Pharmaceuticals at H.C. Wainwright Global Life Sciences Conference

03/09/21 7:00 AM EST

Keyword Search

Year:

03/02/21

Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
Printer Friendly

PDF Version
02/25/21

Summary Toggle TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
Printer Friendly

PDF Version
02/18/21

Summary Toggle TRACON to Report Fourth Quarter and Full Year 2020 Financial Results and Company Highlights on February 25, 2021
Printer Friendly

PDF Version
01/19/21

Summary Toggle TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China for Priority Review
Printer Friendly

PDF Version
01/06/21

Summary Toggle TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
Printer Friendly

PDF Version
12/30/20

Summary Toggle TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines
Printer Friendly

PDF Version
12/29/20

Summary Toggle TRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering
Printer Friendly

PDF Version
12/22/20

Summary Toggle TRACON Pharmaceuticals Announces $8.8 Million Registered Direct Offering
Printer Friendly

PDF Version
12/10/20

Summary Toggle TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial
Printer Friendly

PDF Version
11/23/20

Summary Toggle TRACON Announces Publication in Cancer Cell of Clinical Data that Provides Molecular Insight into the Mechanism of Action of TRC102 and Patient Populations Most Likely to Respond to Treatment
Printer Friendly

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Investor Relations

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2021